Skip to main content

Advertisement

Log in

Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigate whether the serum levels of inflammation-related cytokines might be different between the healthy individuals and the psoriatic patients diagnosed of three varied Chinese medicine (CM) syndromes [blood-stasis syndrome (BSS), blood-dryness syndrome (BDS) and wind-heat syndrome (WHS)].

Methods

A total of 62 psoriatic patients were recruited and assigned to 3 groups according to their CM syndromes, including 27 patients of BSS, 21 of BDS and 14 of WHS. Another 20 sex- and age-matched healthy subjects were enrolled into the control group. Serum concentrations of multiple cytokines, including monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), soluble CD4O ligand (SCD40L), tumor necrosis factor-α (TNF-α), epidermal growth factor (EGF), interleukin-8 (IL-8), interleukin-17 (IL-17), interferon γ inducible protein-10 (IP-10) and vascular endothelial growth factor (VEGF), were measured by a multiplexed flow cytometric assay.

Results

The circulating levels of MIP-1α, TNF-α, IL-8, and IP-10 were significantly increased in the psoriatic patients compared with the healthy controls (P<0.01). Male and female patients tended to have higher serum levels of MCP-1 and IP-10, respectively (P<0.05). Interestingly, compared with the control group, 6 out of the 9 cytokines (MCP-1, MIP-1α, TNF-α, EGF, IL-8 and IP-10) were substantially increased in the BSS group (P<0.05 or P<0.01), whereas only MIP-1α and IL-8 levels were elevated in the BDS group (P<0.05 or P<0.01) concurrent with lowered concentrations of SCD40L and IL-17 (P<0.05). In the WHS group, MIP-1α was the only cytokine whose level was evidently increased (P<0.01), in contrast to IL-17 which was decreased as compared with the control (P<0.05). The psoriatic patients overall owned higher levels of MIP-1α and IL-8 in the circulation which were comparable among the 3 groups of CM syndromes (P<0.01). In contrast, TNF-α level of the BSS group was the highest among the three (P<0.01), followed by the BDS and the WHS groups.

Conclusions

The expression profiles of cytokines in the circulation might not be necessarily identical for psoriatic patients with different CM syndromes. Accordingly, the serum concentrations of certain cytokines could potentially be used as the ancillary indices for the clinical classification of psoriatic CM syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Liu W, Zhao G, Liu YF. Proliferation response of peripheral blood mononuclear cells to streptococcus M6 protein in patients with psoriasis. J Fourth Milit Med Univ (Chin) 2003;24:1213–1215.

    CAS  Google Scholar 

  2. Skov L, Kragballe K, Zachariae C, Obitz ER, Holm EA, Jemec GB, et al. HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch Dermatol 2003;139:1433–1439.

    Article  CAS  PubMed  Google Scholar 

  3. Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP. The pathogenesis of inflammatory dermatoses, expecially psoriasis. Ned Tijdschr Geneeskd 2006;150:179–183.

    CAS  PubMed  Google Scholar 

  4. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007;356:580–592.

    Article  CAS  PubMed  Google Scholar 

  5. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005;11:43–49.

    Article  CAS  PubMed  Google Scholar 

  6. Deng BX, Jiang CY, Wang P, liu WL, Qu X, Zhao YM, et al. Rule of distribution and development of TCM syndromes of psoriasis. J Tradit Chin Med (Chin) 2006;47:770–772.

    Google Scholar 

  7. Zhang GZ, Wang P, Wang JS, Jiang CY, Deng BX, Li P, et al. Study on the distribution and development rules of TCM syndromes of 2651 psoriasis vulgaris cases. J Tradit Chin Med (Chin) 2008;49:894–896.

    Google Scholar 

  8. An JY, Jin L. Traditional Chinese medicine progress research of psoriasis with blood-stage treatment. Chin J Dermatovenerol Integr Tradit West Med (Chin) 2009;8:59–61.

    Google Scholar 

  9. Psoriasis Study Group, Skin Venereal Diseases Branch of Chinese Medical Association. Guideline for the treatment of psoriasis (2008). Chin J Dermatol (Chin) 2009;42:213–214.

    Google Scholar 

  10. Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijing: China Medical Science Press; 2002:229–300.

    Google Scholar 

  11. Wang L, Yang L, Gao L, Gao TW, Li W, Liu YF. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis. Int J Immunogenet 2008;35:45–49.

    Article  PubMed  Google Scholar 

  12. Kaur S, Zilmer K, Leping V, Zilmer M. Comparative study of systemic inflammatory responses in psoriasis vulgaris and mild to moderate allergic contact dermatitis. Dermatology 2012;225:54–61.

    Article  CAS  PubMed  Google Scholar 

  13. Szodoray P, Alex P, Chappell-Woodward CM, Madland TM, Knowlton N, Dozmorov I, et al. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology (Oxford) 2007;46:417–425.

    Article  CAS  Google Scholar 

  14. Chen JS, Zheng M. Expression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in patients with psoriasis. Chin J Dermatol (Chin) 2002;35:111–113.

    Google Scholar 

  15. Jin L, Jiang YS, Cai NN, Wang P. Expression of VEGF in skin lesions and serum level in patients of psoriasis vulgaris with TCM differentiation-types. Chin J Derm Venereol (Chin) 2006;20:406–408.

    CAS  Google Scholar 

  16. Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol 2012;7:385–422.

    Article  CAS  PubMed  Google Scholar 

  17. Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005;2005:273–279.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2010;35:645–649.

    Article  CAS  PubMed  Google Scholar 

  19. Cai Y, Shen X, Ding C, Qi C, Li K, Li X, et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 2011;35:596–610.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Erturan I, Köroğlu BK, Adiloğlu A, Ceyhan AM, Akkaya VB, Tamer N, et al. Evaluation of serum SCD40L and homocysteine levels with subclinical atherosclerosis indicators in patients with psoriasis: a pilot study. Int J Dermatol 2014;53:503–509.

    Article  CAS  PubMed  Google Scholar 

  21. Gerdes S, Osadtschy S, Buhles N, Baurecht H, Mrowietz U. Cardiovascular biomarkers in patients with psoriasis. Exp Dermatol 2014;23:322–325.

    Article  CAS  PubMed  Google Scholar 

  22. Witowski J, Ksiazek K, Jörres A. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 2004;61:567–579.

    Article  CAS  PubMed  Google Scholar 

  23. Zhang P, Zhang R, Zhou XY. The expression and significant of IL-17 in psoriatic lesions. Chin J Dermatovenereol (Chin) 2010;24:13–15.

    Google Scholar 

  24. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005;64:ii30–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9–22.

    CAS  PubMed  Google Scholar 

  26. Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol 2010;163:1282–1290.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chuan-jian Lu  (卢传坚).

Additional information

Supported by the Financial Industry Technology Research and Development Program of Guangdong Province, China (No. 201105)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xuan, Ml., Lu, Cj., Han, L. et al. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes. Chin. J. Integr. Med. 21, 108–114 (2015). https://doi.org/10.1007/s11655-014-1792-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-014-1792-0

Keywords

Navigation